Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 104132, 6 pages
http://dx.doi.org/10.1155/2015/104132
Review Article

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

Washington University School of Medicine, St. Louis, MO 63110, USA

Received 5 November 2014; Accepted 27 January 2015

Academic Editor: Federico Salomone

Copyright © 2015 Brian N. Finck and Angela M. Hall. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. V. Farese Jr., R. Zechner, C. B. Newgard, and T. C. Walther, “The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 570–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Zhou, G. Llauradó, M. Orešič, T. Hyötyläinen, M. Orho-Melander, and H. Yki-Järvinen, “Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2,” Journal of Hepatology, 2014. View at Publisher · View at Google Scholar
  3. S. Sookoian and C. J. Pirola, “Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease,” Hepatology, vol. 53, no. 6, pp. 1883–1894, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. R. Rando and N. Young, “The stereospecific activation of protein kinase C,” Biochemical and Biophysical Research Communications, vol. 122, no. 2, pp. 818–823, 1984. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Kumashiro, D. M. Erion, D. Zhang et al., “Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 39, pp. 16381–16385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Cantley, T. Yoshimura, J. P. G. Camporez et al., “CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 5, pp. 1869–1874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Turinsky, D. M. O'Sullivan, and B. P. Bayly, “1,2-diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo,” Journal of Biological Chemistry, vol. 265, no. 28, pp. 16880–16885, 1990. View at Google Scholar · View at Scopus
  8. A. L. Birkenfeld, H. Y. Lee, F. Guebre-Egziabher et al., “Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice,” Cell Metabolism, vol. 14, no. 2, pp. 184–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Choi, D. B. Savage, L. Abu-Elheiga et al., “Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 42, pp. 16480–16485, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Erion, I. D. Ignatova, S. Yonemitsu et al., “Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein,” Cell Metabolism, vol. 10, no. 6, pp. 499–506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. R. Jornayvaz, A. L. Birkenfeld, M. J. Jurczak et al., “Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 14, pp. 5748–5752, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Neschen, K. Morino, L. E. Hammond et al., “Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice,” Cell Metabolism, vol. 2, no. 1, pp. 55–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. B. Savage, S. C. Cheol, V. T. Samuel et al., “Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 817–824, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. T. Samuel, Z.-X. Liu, X. Qu et al., “Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32345–32353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Nagai, S. Yonemitsu, D. M. Erion et al., “The role of peroxisome proliferator-activated receptor γ coactivator-1 β in the pathogenesis of fructose-induced insulin resistance,” Cell Metabolism, vol. 9, no. 3, pp. 252–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Nakajima and O. Yukawa, “Mechanism of radiation-induced diacylglycerol production in primary cultured rat hepatocytes,” Journal of Radiation Research, vol. 40, no. 2, pp. 135–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Toriumi, Y. Horikoshi, R. Yoshiyuki Osamura, Y. Yamamoto, N. Nakamura, and S. Takekoshi, “Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway,” Laboratory Investigation, vol. 93, no. 2, pp. 218–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yoon, Y. Maruyama, A. Kazusaka, and S. Fujita, “Accumulation of diacylglycerol induced by CCl4-derived radicals in rat liver membrane and its inhibition with radical trapping reagent—FT-IR spectroscopic and HPLC chromatographic observations,” Japanese Journal of Veterinary Research, vol. 47, no. 3-4, pp. 135–144, 2000. View at Google Scholar · View at Scopus
  20. Y. Takai, A. Kishimoto, U. Kikkawa, T. Mori, and Y. Nishizuka, “Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system,” Biochemical and Biophysical Research Communications, vol. 91, no. 4, pp. 1218–1224, 1979. View at Publisher · View at Google Scholar · View at Scopus
  21. V. T. Samuel, Z.-X. Liu, A. Wang et al., “Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 739–745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Bezy, T. T. Tran, J. Pihlajamäki et al., “PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2504–2517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Erion, S. Yonemitsu, Y. Nie et al., “SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 27, pp. 11288–11293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Zhang, Z.-X. Liu, S. C. Cheol et al., “Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17075–17080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Frangioudakis, J. G. Burchfield, S. Narasimhan et al., “Diverse roles for protein kinase C δ and protein kinase C ε in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C δ,” Diabetologia, vol. 52, no. 12, pp. 2616–2620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Brown, J. L. Betters, C. Lord et al., “CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance,” Journal of Lipid Research, vol. 51, no. 11, pp. 3306–3315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Monetti, M. C. Levin, M. J. Watt et al., “Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver,” Cell Metabolism, vol. 6, no. 1, pp. 69–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Hoy, C. R. Bruce, S. M. Turpin, A. J. Morris, M. A. Febbraio, and M. J. Watt, “Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation,” Endocrinology, vol. 152, no. 1, pp. 48–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Hall, N. Soufi, K. T. Chambers et al., “Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice,” Diabetes, vol. 63, no. 7, pp. 2284–2296, 2014. View at Publisher · View at Google Scholar
  30. P. J. Voshol, G. Haemmerle, D. M. Ouwens et al., “Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice,” Endocrinology, vol. 144, no. 8, pp. 3456–3462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Turpin, A. J. Hoy, R. D. Brown et al., “Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice,” Diabetologia, vol. 54, no. 1, pp. 146–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. T. Ong, M. T. Mashek, S. Y. Bu, and D. G. Mashek, “Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation,” The FASEB Journal, vol. 27, no. 1, pp. 313–321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Sun, R. A. Miller, R. T. Patel et al., “Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration,” Nature Medicine, vol. 18, no. 6, pp. 934–942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Donkor, M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue, “Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3450–3457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. G.-S. Han, W.-I. Wu, and G. M. Carman, “The Saccharomyces cerevisiae lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme,” Journal of Biological Chemistry, vol. 281, no. 14, pp. 9210–9218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. C. Gropler, T. E. Harris, A. M. Hall et al., “Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting andobesity in mice,” The Journal of Biological Chemistry, vol. 284, no. 11, pp. 6763–6772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Ryu, K.-J. Oh, H.-Y. Jo et al., “TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1,” Cell Metabolism, vol. 9, no. 3, pp. 240–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Ryu, W.-Y. Seo, Y.-S. Yoon et al., “Endoplasmic reticulum stress promotes LIPIN2-dependent hepatic insulin resistance,” Diabetes, vol. 60, no. 4, pp. 1072–1081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hu, H. Yin, M. S. Mitra et al., “Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice,” Hepatology, vol. 58, no. 6, pp. 1953–1963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Hall, K. Kou, Z. Chen et al., “Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver,” Journal of Lipid Research, vol. 53, no. 5, pp. 990–999, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. J. Lee, E. H. Ko, J. E. Kim et al., “Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 34, pp. 13656–13661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Soufi, A. M. Hall, Z. Chen et al., “Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice,” The Journal of Biological Chemistry, vol. 289, no. 43, pp. 30177–30188, 2014. View at Publisher · View at Google Scholar
  43. C.-L. E. Yen, M.-L. Cheong, C. Grueter et al., “Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding,” Nature Medicine, vol. 15, no. 4, pp. 442–446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Zimmermann, J. G. Strauss, G. Haemmerle et al., “Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase,” Science, vol. 306, no. 5700, pp. 1383–1386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. W. Wu, S. P. Wang, F. Alvarez et al., “Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis,” Hepatology, vol. 54, no. 1, pp. 122–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Lass, R. Zimmermann, G. Haemmerle et al., “Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome,” Cell Metabolism, vol. 3, no. 5, pp. 309–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. S. Choi, D. B. Savage, A. Kulkarni et al., “Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance,” The Journal of Biological Chemistry, vol. 282, no. 31, pp. 22678–22688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Y. Park, H. J. Kim, S. Wang et al., “Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 289, no. 1, pp. E30–E39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. B. N. Reid, G. P. Ables, O. A. Otlivanchik et al., “Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis,” The Journal of Biological Chemistry, vol. 283, no. 19, pp. 13087–13099, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. A. V. Chibalin, Y. Leng, E. Vieira et al., “Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance,” Cell, vol. 132, no. 3, pp. 375–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. M. S. Brown and J. L. Goldstein, “Selective versus total insulin resistance: a pathogenic paradox,” Cell Metabolism, vol. 7, no. 2, pp. 95–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. R. K. Semple, A. Sleigh, P. R. Murgatroyd et al., “Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis,” The Journal of Clinical Investigation, vol. 119, no. 2, pp. 315–322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. E. J. Bae, J. Xu, D. Y. Oh et al., “Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance,” Journal of Biological Chemistry, vol. 287, no. 22, pp. 18769–18780, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Li, M. S. Brown, and J. L. Goldstein, “Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3441–3446, 2010. View at Publisher · View at Google Scholar · View at Scopus